email invitation

Dear Colleagues,

We hope this email finds you well. We would like to invite you to participate in the 2^nd HPV Serology Standardization Meeting. This will take place virtually via WebEx from 9:00am – 1:00pm EDT on Tuesday, June 29 and Wednesday, June 30, 2021. Please let us know if you will be available to participate in this meeting by COB April 19, 2021, by emailing back Marissa Blackburn, marissa.blackburn@nih.gov with your confirmation.

The goal of the meeting is to bring together key stakeholders to review progress of HPV serology standardization efforts, identify remaining gaps and actions plans to bridge these gaps. HPV serology is increasingly important for public health decisions. A number of ongoing vaccine trials will be using HPV serology data as primary endpoints for new vaccine recommendations and new vaccines. This meeting will review progress of the HPV serology standardization work (including standards and critical reagents productions, assay development and validation) and guidelines for use of available reference materials/standards. In addition, developments and challenges of currently available HPV serology assays, as well as serological assessments planned for ongoing and new immunobridging vaccine trials will be presented and discussed.

We are currently working on the agenda of the meeting, which will be emailed to you and uploaded on the registration site later in April.

To register for this virtual meeting, please go to https://events.cancer.gov/nci/hpvserology. There is no registration fee for attending this meeting, however all attendees are required to individually register. Registration is not complete until the form is submitted.

We look forward to working with you and having you participate in this meeting. Please do not hesitate to contact us if you have any questions concerning the meeting.

Sincerely,

Ligia A. Pinto